Meeder Asset Management Inc Idera Pharmaceuticals, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.53 - $1.03 $441 - $857	-833 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$1.23 - $5.98 $1,024 - $4,981	833 New	833 $1,000
Q4 2020 Feb 09, 2021	SELL	$2.09 - $5.18 $9,937 - $24,630	-4,755 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.45 - $2.79 $1,326 - $2,552	915 Added 23.83%	4,755 $9,000
Q3 2019 Oct 17, 2019	BUY	$2.12 - $3.31 $6,455 - $10,078	3,045 Added 383.02%	3,840 $11,000
Q2 2019 Aug 05, 2019	BUY	$2.37 - $3.97 $149 - $250	63 Added 8.61%	795 $2,000
Q1 2019 Apr 16, 2019	SELL	$2.33 - $3.79 $95 - $155	-41 Reduced 5.3%	732 $2,000
Q4 2018 Jan 17, 2019	BUY	$2.77 - $9.38 $1,168 - $3,958	422 Added 120.23%	773 $2,000
Q3 2018 Nov 02, 2018	BUY	$5.53 - $11.36 $1,941 - $3,987	351 New	351 $0

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.